Cabaletta Bio, Inc. (CABA) Financials
CABA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 173.3 million | 12.4 million |
2023-06-30 | 184.6 million | 10.5 million |
2023-03-31 | 103.4 million | 11.8 million |
2022-12-31 | 117.0 million | 12.4 million |
CABA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -12.7 million | 3.0 million |
2023-06-30 | -11.9 million | 2.8 million |
2023-03-31 | -13.0 million | 2.5 million |
2022-12-31 | -12.4 million | 1.6 million |
CABA Net Income
No data available :(
CABA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 164.4 million | - | 4.3 million |
2023-06-30 | 176.3 million | - | 4.2 million |
2023-03-31 | 93.8 million | - | 4.7 million |
2022-12-31 | 106.5 million | - | 5.1 million |
CABA Shares Outstanding
CABA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 65000 | 13.8 million | 4.9 million | - |
2023-06-30 | 57000 | 11.8 million | 4.1 million | - |
2023-03-31 | 380000 | 12.4 million | 4.5 million | - |
2022-12-31 | 316000 | 12.4 million | 3.9 million | - |
CABA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 355000 |
2023-06-30 | - | 833000 |
2023-03-31 | - | 817000 |
2022-12-31 | - | 2.9 million |
CABA
Price: $12.39
52 week price:
Earnings Per Share: -1.65 USD
P/E Ratio: -14.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 489500
Market Capitalization: 907.9 million